Although the pro-angiogenic effect of CD11b+CX3CR1+ monocytes has not been well described in human cancer types, these findings suggest that CD11b+CX3CR1+ monocytes might promote tumor growth and progression by enhancing angiogenesis in DLBCL. This evidence concerns the gene CX3CR1 and diffuse large B-cell lymphoma.